Opendata, web and dolomites


EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector

Total Cost €


EC-Contrib. €






 EMBRYON project word cloud

Explore the words cloud of the EMBRYON project. It provides you a very rough idea of what is the project "EMBRYON" about.

favoring    physician    pregnancy    scan    ph2    trials    double    last    solutions    images    italy    fertilization    infertility    therapy    issue    patterns    approximate    big    regulation    acs    morphological    costly    outcomes    safer    instruments    certify    identification    100    ethical    clinical    diagnostic    compliant    improves    cycle    lab    prototype    forecasts    despite    handcrafted    fda    embryos    commercial    precision    six    imaging    scientists    cycles    reactivity    ww    validated    simpler    gross    overcoming    revenues    proprietary    subjective    15    20    extension    lifetime    rate    stressful    reproductive    1400    introduces    units    favored    smarter    partnership    global    nikon    transferred    2020    easier    market    cheaper    algorithms    heavy    ll    deep    deeper    nearly    rates    specialists    patented    ce    newco    births    social    ongoing    finalize    ph1    sales    observations    embryon    2013    image    software    clinics    embryo    vitro    generation    automated    shape    publish    ivf    optimization    billion    1200    leader    clearance    invasive    innovation    innovations    merges    45    leaving    patents    predictors    utero    couples    switzerland    million    dollars    procedure    10    amongst    validation    microscopy    plan    patients    microscope    org   

Project "EMBRYON" data sheet

The following table provides information about the project.


Organization address
city: ROMA
postcode: 139

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ADVANCED COMPUTER SYSTEMS A.C.S. SPA IT (ROMA) coordinator 50˙000.00


 Project objective

Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime. In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013. Despite stressful and costly procedures,IVF success rate is low (15-20% births/cycle),leaving big opportunities for innovation and process optimization. EMBRYON introduces to IVF clinics and specialists a last-generation diagnostic-imaging system,favoring better outcomes through deeper,smarter analysis of clinical images. It merges tailored image-processing software and algorithms,patented by ACS,with a high-end commercial IVF microscope.A prototype is under validation with top clinics in Italy and Switzerland,supported by Nikon Instruments (global leader in IVF microscopy). EMBRYON improves the key success factor of any IVF procedure:the identification of 1-2 embryos with best “pregnancy potential” to be transferred in utero,amongst 5-10 generated in vitro. EMBRYON’s precision is double than current handcrafted approaches,favoring higher success rates. It is safer (100% not invasive),thus simpler to certify and adopt,fully compliant with ethical regulation,easier to use (no change to lab procedures) and cheaper than similar products. Key innovations 1. Automated deep scan of embryo shape,overcoming today’s subjective and approximate observations carried by the physician 2. Proprietary algorithms for the measurement of complex morphological patterns,strong predictors of potential Sales forecasts are 1200-1400 units (40-45 M€ gross revenues) by 2020 in Europe and US,favored by: - High reactivity of the IVF sector (scientists/patients) to validated solutions improving outcomes - Commercial partnership with a global IVF microscopy leader In Ph1 we’ll finalize and publish the ongoing clinical studies and make a deep market analysis for Europe-US In Ph2 we plan CE/FDA clearance,WW extension of patents,3 trials in Europe-US,set-up of newco and sales org

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More